The Phenolic Content of <i>Pistacia lentiscus</i> Leaf Extract and Its Antioxidant and Antidiabetic Properties

Bouakline, Hamza; Bouknana, Saliha; Merzouki, Mohammed; Ziani, Imane; Challioui, Allal; Bnouham, Mohamed; Tahani, Abdesselam; EL Bachiri, Ali

doi:https://doi.org/10.1155/2024/1998870

The Scientific World Journal

On this page

Abstract Introduction Materials and Methods Results and Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2024 | Article ID 1998870 | https://doi.org/10.1155/2024/1998870

The Phenolic Content of Pistacia lentiscus Leaf Extract and Its Antioxidant and Antidiabetic Properties

Hamza Bouakline,¹Saliha Bouknana,²Mohammed Merzouki,³Imane Ziani,¹Allal Challioui,³Mohamed Bnouham,²Abdesselam Tahani,¹and Ali EL Bachiri¹

Academic Editor: Raimo Pohjanvirta

Received06 Apr 2023

Revised28 Dec 2023

Accepted20 Jan 2024

Published07 Feb 2024

Abstract

The aims of this study were to determine the polyphenolic profile, to estimate the total phenolic and flavonoid contents, and to evaluate the antioxidant and antidiabetic activities of the extract of Pistacia lentiscus leaves, and the hydroacetonic mixture was employed as an alternative for common solvents in the extraction process. In order to explain the antidiabetic activity, molecular docking has been performed on the main constituents of the leaf extract. The characterization of the extract has been performed by high-performance liquid chromatography (HPLC) leading to the detection of 20 compounds of which gallic acid, ellagic acid, catechin, kaempferol, and quercetin 3-glucoside were identified using authentic standards. The total phenolic and flavonoid contents, assessed using the Folin–Ciocalteu and quercetin methods, were 394.5 ± 0.08 mg gallic acid equivalent/g dry extract (mg GAE/g DE) and 101.2 ± 0.095 mg quercetin equivalent/g dry extract (mg QE/g DE), respectively. On the other hand, the antioxidant activity of leaf extract, quantified by determining the ability to neutralize the free radical DPPH and β-carotene/linoleate model system, reached the values of 0.0027 ± 0.002 mg/mL and 0.128 ± 0.04 mg/mL, respectively. Regarding the antidiabetic activity, based on the inhibition of pancreatic α-amylase activity, a significant inhibition of about 68.20% with an IC₅₀ value of 0.266 mg/mL had been observed. This finding is consistent with the molecular docking study of the main phenolic compounds of the extracts, where a remarkable binding affinity against α-amylase was observed, with values of −7.631 (kcal/mol), −6.818 (kcal/mol), and −5.517 (kcal/mol) for the major compounds catechin, quercetin-3-glucoside, and gallic acid, respectively.

1. Introduction

Pistacia lentiscus L., a wild-growing species classified within the family of Anacardiaceae, is one of more than 4,200 varieties, including 600 plants with medicinal and aromatic properties [1, 2]. Several studies into the ethnobotany of the plant under study have been carried out, as previously reported in various works [3–5]. Recently, especially in the new century, products of natural origin, such as essential oils and plant extracts, have attracted the attention of researchers and become popular with consumers. Their use as an alternative to synthetic products [6, 7] appears to reduce production costs and avoid many negative side-effects on human health. Many scientists and researchers are focusing on emerging natural materials such as natural plant extracts, in particular Pistacia lentiscus leaf extract, with the aim of creating new horizons for scientific research on the one hand [8] and, on the other, to investigate potential uses for these natural compounds in the pharmaceutical sector, particularly as antioxidant agents or inhibitors of enzymes such as α-amylase and α-glucosidase. The aim of this study is also to justify the traditional use of this plant in the treatment of various illnesses, including diabetes, as observed in many Third World countries [9, 10].

The chemical profiles of the essential oil and phenolic compounds extracted from the leaves of P. lentiscus were detailed in the study conducted by Amhamdi et al. The researchers identified more than 35 components in the essential oil, with major compounds such as myrcene, limonene, β-gurjunene, and germacrene. In addition, α-pinene and β-pinene were noted as abundant compounds [11]. The extracts contain more than 40 phenolic compounds, classified into three main classes of secondary metabolites [12]. The plant has also been extensively studied for a variety of biological activities, which have been reported to possess antifungal [13], antibacterial [14, 15], antioxidant [16–19], antimalarial, and antiviral activities [20], as well as anti-inflammatory [21], analgesic, and antithermogenic activities [22, 23].

Concerning the antidiabetic activity, research scientists have demonstrated that the extract exhibited significant inhibition of pancreatic amylase at the low doses ranging between 60 and 100 μg/mL [10]. Enzymes such as oxidases participate in various metabolic processes, and their connection to the antidiabetic activity may be indirect. For instance, certain studies propose that antioxidant enzymes, including oxidases, might contribute to alleviating oxidative stress associated with diabetes [9, 24]. Increased oxidative stress is associated with the onset and advancement of diabetes. In addition, some plant-derived compounds with antioxidant properties that could influence the oxidase activity have been studied for their potential antidiabetic effects [25]. Furthermore, some researchers examined the antioxidant efficacy of the extract obtained from the leaves of P. lentiscus and its primary components, both experimentally and theoretically, in order to detect the specificity of the binding between the main compounds identified in the Pistacia lentiscus leaf extract [17, 26].

The essential oil and extract of this plant are effective against Gram-negative bacteria, such as Pseudomonas aeruginosa and Escherichia coli, as well as Gram-positive bacteria including Bacillus subtilis and Listeria monocytogenes [27]. Furthermore, various phytochemical studies have shown the considerable existence of some polyphenolic compounds such as flavonoids [28] and tannoids and also the appearance of sterols, saponins, and triterpenes [29, 30]. Among the reasons that allowed the development of the extract of Pistacia lentiscus leaf, either as an antioxidant agent or as an inhibitor of the enzymes responsible for diabetes to act as a trophic agent on the acinar tissue, to augment the production of enzymes of the cultured islets [31], there is first of all the absence of symptoms of toxicity, and then the abundance and wild growth of this species are additional aspects that qualify for a detailed study. Enhanced by the limited research, even those that are available are focused on the experimental aspect and neglect the theoretical aspects. At this point, in our study, the focus was experimental, examining the performance of the extract and three of its main compounds. These compounds belong to two different families of polyphenols, the flavonoid family and the phenolic acid family. The aim was to determine the effect of the chemical formula rich in polyhydroxyl blocks and its relationship to inhibitory activity. Theoretically, the calculations approved the result obtained. On the toxicity side, Remila [32] proved that although the extract concentration reached 100 μg/mL, no toxicity was observed, in addition to the antioxidant aspect expressed, to the fact that these extracts contain high levels of vitamin C, as reported earlier by Hadini [33] since the amount of vitamin C has reached approximately 22 mg ascorbic acid per 1 g of dried matter of the extract. Hence, the main aims of this research involve elucidating the chemical composition of the hydroacetonic extract obtained from Pistacia lentiscus leaves and quantifying its total phenolic and flavonoid contents. Furthermore, the investigation aims to assess the antioxidant potential and the antidiabetic properties of the extract. Another integral objective is to conduct molecular docking studies of the predominant phenolic compounds. This work is considered one of the first of its kind on this plant combining the antidiabetic activity of its extract and its theoretical explanation.

2. Materials and Methods

2.1. Plant and Material

The Pistacia lentiscus leaves used in this research were collected from the northeastern part of Morocco (altitude: 836 m, 34° 32′ 52.968″N 1° 51′ 25.301″W) in March 2021 (Figure 1). All the reagents, solvents, and standards were purchased from Sigma-Aldrich.

2.2. Procedure of Extraction

An amount of 5 g of grinded leaves was mixed with 50 mL of a hydroacetonic mixture at a ratio of (80/20), respectively, for 12 h under mechanical stirring. The resulting extract was stocked at 4°C for 24 h, followed by vacuum filtration, evaporation under vacuum, and storage until it was needed for the different analyses [34].

2.3. HPLC Analysis

Pistacia lentiscus hydroacetonic extract samples were prepared in MeOH using the rapport of 10 mg in 1 mL, and then filtration with a suitable accessory was done (filter of 0.45 μm pore size), following a direct injection of a volume 10 μL into high-performance liquid chromatography (HPLC-DAD) (Waters Alliance™ e2695 XC HPLC System), which is integrated with a diode array detector (DAD) and also an apolar column C18 (5 µm, 250 mm × 4.6 mm). To start the analysis procedure [35], the polyphenolic compound detection was accomplished by the following steps and the gradient mode was used as an elution program with a flow rate of 0.7 mL/min. Water 0.75% and the rest of acetic acid were used as the first eluent (A) on the one hand and the methanol as the second eluent (B) on the other; the elution operation was performed according to the gradient in Table 1, as described by Khodir et al., with some modifications [36].

2.4. Determination of Total Phenol Content

The procedure for determining total phenols was executed using the Folin–Ciocalteu method. In each test tube, a volume of 1500 μL of sodium carbonate solution (20%) was added over to 1000 μL of distilled water and 0.5 mL of Folin–Ciocalteu phenolic reagent (10%) as well as 0.1 mL of the samples to be tested. The absorbance of the samples was measured at 760 nm using a T80+ UV-Vis spectrophotometer, after plotting gallic acid as a standard curve with the following concentrations: 0.01, 0.02, 0.03, 0.04, 0.05, and 0.1 mg/ml. The results were expressed as mg of gallic acid equivalent/gram of dry extract (mg GAE/g DE) [10].

2.5. Determination of Flavonoid Content

The flavonoids were measured spectrophotometrically by using colorimetric methods, by adding 500 μL of a solution of 133 mg of AlCl₃ ‏along with 400 mg of CH₃CO₂Na dissolved in 100 mL of distilled water to 1 mL of the extract samples (500 μg/mL), followed by the recording of the absorbance values at 430 nm. The plotting of standard curve of quercetin with the following concentrations, 0.01, 0.02, 0.03, 0.04, 0.05, and 0.1 mg/ml, led to the following: mg quercetin equivalent/gram of dry extract (mg QE/g DE) [10].

2.6. In Vitro Antioxidant Activity

2.6.1. DPPH Free Radical Scavenging Assay

The antioxidant activity of extracts is tested by using the capacity of antioxidants to scavenge the free radical 2,2-diphenyl-1-picrylhydrazyl. After preparing a DPPH solution in methanol 0.004%, 2.4 mL was then mixed with 0.6 mL of a series of extracts of varying concentrations, and all the absorbance changes were measured at 517 nm. The values obtained from absorbance measurement are used for the determination of the IC₅₀ values, which indicate the antioxidant capacity relative to the values of vitamin C (ascorbic acid) used as a standard [37] according to the following formula:where A0 = the absorbance of the control sample and AE = the absorbance of the sample.

2.6.2. β-Carotene Bleaching Model System (BBC)

Based on the concept that the presence of natural antioxidant compounds could neutralize the linoleate free radical, therefore preventing the bleaching of β-carotene, the BBC assay for the Pistacia lentiscus leaf extract was determined, following the protocol applied by Bekkouch et al. [38], with few modifications. Briefly, the β-carotene/linoleic acid emulsion was prepared by dissolving 2 mg in 10 mL of chloroform, followed by a quick addition of 20 mg of linoleic acid and 200 mg of the Tween-80. Next, the chloroform evaporated, and 100 mL of the bidistilled water was added. For the test execution, 2.5 mL of the emulsion solution formed was blended with 0.5 mL of the hydroacetonic extracts or butylated hydroxyanisole (BHT) solution at various concentrations. The absorbance was determined using a UV-Vis spectrophotometer at 470 nm at t = 0 and at t = 120 min after 2 h incubation at 50°C in a water bath. The inhibition efficiency was calculated according to the following formula:where AE (0) and AE (120) sample absorbances were at 0 min and 120 min, respectively, and AC (0) and AC (120) control absorbances were at 0 min and 120 min, respectively.

2.7. In Vitro Antidiabetic Activity

The in vitro antidiabetic activity based on the inhibition of pancreatic α-amylase activity was performed on the hydroacetonic extract according to the method of Bouknana et al. [39]. The following concentrations of the extract were tested: 0.05, 0.11, 0.23, and 0.45 mg/ml. In brief, each test tube received 200 µL of extract and 200 µL of α-amylase and was incubated at 37°C for 10 minutes. The mixture was then reincubated for 15 minutes at 37°C with 200 µL of 1% starch solution added to each test tube. In order to stop the reaction, 600 μL DNSA reagent (30 g of sodium potassium tartrate tetrahydrate in 20 ml of 2 M NaOH and 40 mL of 96 mM of 3,5-dinitrosalicylic acid solution) was added, as a next step for 8 min, and the mixture was boiled in a boiling water bath. Next, the mixture was cooled at room temperature and diluted with 1 mL of deionized water. On the other hand, a blank with 100% enzyme activity was prepared by replacing the sample volume (200 μL) with the phosphate buffer solution. Blank reaction was equivalently adjusted using samples at each concentration in the absence of blank solution. Acarbose has been used as a positive control sample. All the absorbance measurements were performed at 540 nm.

The inhibition percentage was calculated using the following formula:where Ac = the absorbance of the control sample and Aa = the absorbance of the sample.

2.8. Molecular Docking

The six selected compound structures were obtained from the online PubChem database [40]. The 3D structures and the geometric optimizations with ligand energy minimization were performed using controlled algorithms in Schrodinger 2018-1. Then, the LigPrep module was used by adding hydrogen atoms and eliminating salt and ionization at pH (7 ± 2). Concerning α-amylase, molecular docking was achieved from the X-ray crystal structure of human pancreatic α-amylase complexing with mini-montbretin A (PDBID: 5 E0F) [40], with a resolution of 1.40 Å. The free R value is 0.181, and the working R value is about 0.155. The observed R value is also 0.156. The protein structure was prepared using the protein preparation wizard (Schrodinger 2018-1), where the water atoms and all the ligands were detached, although the nonpolar hydrogens were fused. The active site binding α-amylase with mini-montbretin A was chosen as the gate centers. The dimensions of the central grid box were chosen to include all atoms of the ligand set. The grid box site in α-amylase was fixed at −8.29, 21.6, and −18.72 Å (for x, y, and z) using 40, 40, and 40 points (for x, y, and z) and using the standard precision (SP) glide score to predict binding free energy and ligand strain energy to select docked poses; the binding affinity (kcal/mol) is the description of the output docking scores. Energy minimization was performed by default by limiting RMSD to 0.3 Å. Finally, to minimize the structure of the protein, the OPLS3 force field was used [40]. The conformations taken into consideration are those with minimal binding energy. They are converted into a three-dimensional diagram displaying the binding interaction of the ligand with the site of the active residues.

2.9. Statistical Analysis

The analyses were carried out in triplicate, and all the results were analyzed using “OriginPro version 2018” software and presented as mean values with standard error.

3. Results and Discussion

3.1. Qualitative Identification of Chemical Composition of Extracts

The chemical profiles of polyphenolic compounds obtained from Pistacia lentiscus leaf extract using HPLC-DAD analysis, with an extraction rate of 39.5%, at two different wavelengths’ relative maximum absorbance are presented in Figure 2. The chromatograms revealed the presence of numerous polyphenolic molecules. The identification of some selected phenolics in the extract was carried out using standards, such as gallic acid, catechin, ellagic acid, kaempferol, and quercetin 3-glucoside, by comparing their retention times and (Table 2).

(a)

(b)

The present study supports a previous report on the presence of the gallic acid, p-coumaric acid, and syringic acid as the major phenolic compounds in Pistacia lentiscus leaf extracts [41]. Another investigation on Pistacia lentiscus leaves carried out by Romani et al. revealed the detection of gallic acid, glucose, quinic acid, myricetin, quercetin, cyanidin 3-O-glucoside, and 3-O-glucoside, with some traces of catechin [12]. Also, our findings are consistent with those reported by Ouahabi et al.; this applies to the leaves of Pistacia lentiscus collected in the eastern region of Morocco. It was found that the extract contains many phenolic compounds, such as catechin, quercetin, and p-coumaric acid, along with other notable compounds [42].

3.2. Determination of Total Phenol and Flavonoid Contents

The phenolic compound contents estimated from Pistacia lentiscus leaf (hydroacetonic) extract are 394.5 ± 0.08 (mg GAE/g DE) for the polyphenols and 101.2 ± 0.095 (mg QE/g DE) for the flavonoids, all of which are listed in Table 3. Concerning the polyphenolic contents in the Pistacia lentiscus leaves from the northeastern part of Algeria, values of 517.512 ± 5.53 (mg GAE/g) and 108.67 ± 0.5 (mg QE/g) for the flavonoids were obtained according to Mehenni et al. [10], which are in conformity with the results of our study, and this is primarily due to the geographic proximity of the two harvesting regions. On the other hand, the Bampouli research team came out with 314.88 ± 0.01 (mg GAE/g extract) and 65.18 ± 0.02 (mg QE/g extract) values as a result for polyphenols and flavonoid, respectively [43]. With the aim of comparison, other authors announced that the total phenolic contents of Pistacia lentiscus leaf extract from Morocco were 345.95 ± 1.17 (mg GAE/g) [44].

3.3. Antioxidant Activity

The in vitro antioxidant activity performed on the plant extracts has shown a remarkable ability to neutralize free radicals DPPH, IC₅₀ = 0.0027 ± 0.002 mg/mL (Figure 3 and Table 3), which is explained by the existence of a high amount of ascorbic acid in extract as Hadini et al. reported [33]. Furthermore, the presence of many different natural antioxidant components such as phenols, flavonoids, and tannins in the plant extract, as already mentioned by the investigation of Bouakline et al. in which the antioxidant activity of the hydroacetonic leaf extract, using the DPPH assays, was tested experimentally and confirmed theoretically by the interaction energy among DPPH and gallic acid, catechin, and quercetin [26]; to support the result of the present study, Yosr et al. [34] announced about this ability of Pistacia lentiscus extracts, whereas they found that IC₅₀ = 5.7 ± 0.5 μg/mL. Nevertheless, a value of IC₅₀ = 0.09 ± 0.00 mg/mL was reported by Barbouchi et al. [44]. However, other different parts of Pistacia lentiscus L. extracts have been evaluated for the DPPH antioxidant test, and the leaf extract showed higher ability than that of the other parts [19, 45]. Furthermore, the IC₅₀ of Pistacia lentiscus leaf extract of our current study was slightly lower than the synthetic antioxidants of the ascorbic acid, with the IC₅₀ values of 0.0030 ± 0.003 mg/mL.

(a)

(b)

The antioxidant activity of the hydroacetonic extracts was evaluated in order to investigate their capacity to inhibit or reduce the bleaching of β-carotene as is listed in the table. As a result, the Pistacia lentiscus leaf extracts have shown a good performance to inhibit the bleaching of β-carotene by scavenging the free radicals formed within the system including the linoleate ones. The concentration 0.128 ± 0.04 mg/mL was recorded to be the value required to give 50% inhibition in the current study, which is different from butylated hydroxyanisole and the pure synthetic standards, IC₅₀ = 0.004 ± 0.009 mg/mL; our result was similar to the one of Amessis-Ouchemoukh et al. where IC₅₀ found was 0.12 ± 0.00 mg/mL for the methanolic extract of the Pistacia lentiscus growing in the suburbs of Bajaia City in Algeria [46]. On the other hand, the different organs of the plant under study were tested as potential natural antioxidants, where the highest activity was observed in leaf extracts with IC₅₀ = 0.166 ± 0.001 mg/mL compared to the stems, fruits, and roots with the following values, 0.076 ± 0.001 mg/mL, 0.772 ± 0.043 mg/ml, and 0.370 ± 0.002 mg/mL, respectively [45]. Based on the literature, Ouahabi et al. reported that the Pistacia lentiscus leaf extract possesses β-carotene bleaching activity comparable to the value obtained in our study, with an IC₅₀ value of 0.19 mg/ml [42]. Our obtained results have shown that the high polyphenol content could probably affect the oxidative power of the extract, which is in accordance with the literature search which indicated that higher antioxidant activity was related directly to the high amount of phenolic compounds [46].

3.4. Antidiabetic Activity

The in vitro antidiabetic activity performed on Pistacia lentiscus leaf extract presented an interesting result concerning the inhibition of α-amylase. The inhibition results were 17.75%, 41.11%, 46.64%, and 68.20% for the following concentrations of 0.05 mg/mL, 0.11 mg/mL, 0.23 mg/mL, and 0.45 mg/mL, respectively, with an IC₅₀ value of 0.266 ± 0.01 mg/mL, as shown in Figure 4 and Table 3. This result is mainly due to the major polyphenol and flavonoid constituents such as catechin, quercetin, and gallic acid, which were also examined as prospective antidiabetic substances, which have an important IC₅₀ represented by, IC₅₀ = 0.174 ± 0.001 mg/mL, IC₅₀ = 0.058 ± 0.05 mg/mL, and IC₅₀ = 0.098 ± 0.001 mg/mL for catechin, quercetin, and gallic acid, respectively, to inhibit the alfa amylase enzyme. Specifically, the catechin, as a compound of the flavonoid family, classified as flavanol subclass, had a significant effect at low concentrations of 0.05 mg/mL, with inhibitory activity greater than other components, as quercetin from the same family listed as the flavonol subgroup. On the same approach, previous works, regarding flavones as flavonoids, were tested, indicating that the position of the hydroxyl group or H group on the ring of flavonoids along with their molecular volume had a significant effect on the inhibitory activity [47, 48]. However, some phenomena were observed in the inhibitory activity of flavonoids with a similar chemical structure in which myricetin was 40 times more effective than dihydromyricetin, which was explained by the results of molecular docking, where it was concluded that the different orientations in the active center of α-amylase may be an influencing factor on the inhibitory activity [48]. For the acidic phenol family represented by gallic acid, its effect was manifested at slightly higher concentrations of 0.23 mg/mL and 0.45 mg/mL, strengthening the hypothesis of the effect of the poly-hydroxyl group of the chemical formula and its effect on the inhibition rate. With such characteristics, many studies have shown and concentrated on these bioactive compounds as the compounds with important antidiabetic properties [49, 50]. A similar study conducted by Mehenni et al. agrees with our currently obtained results [10]. The study result of Foddai et al. revealed the presence of a great capacity of Pistacia lentiscus extract to chelate the enzyme as α-amylase [51].

3.5. Molecular Docking

The study of the binding interactions of the six compounds with the α-amylase pocket was conducted to identify their inhibitory mechanism and to determine the active α-amylase site that allows hydrolysis comprising 3 large amino acids: GLU233, ASP300, and ASP197. The binding interactions of the compounds studied with respect to acarbose had sharing interactions, which showed that acarbose binds by five conventional hydrogen bonds with ASP300, ASP197, GLU233, HIE299, and ASP356. Quercetin-3-glucoside and acarbose have three similar hydrogen bonds with ASP300, ASP197, and GLU233, as shown in Figure 5. Besides, catechin and kaempferol have two hydrogen bonds similar to the active α-amylase site. Therefore, the majority of the studied compounds interact with the active α-amylase site via the hydrogen bonds, which leads to a good binding affinity against α-amylase, as shown in Table 4. Catechin, quercetin-3-glucoside, and kaempferol showed powerful α-amylase binding energy values than ellagic acid and gallic acid, with the following docking scores −7.631 kcal/mol, −6.818 kcal/mol, −6.204 kcal/mol, −5.320 kcal/mol, and −5.517 kcal/mol, respectively. Thus, the present result revealed that most of the compounds have minimal docking scores and remarkable binding affinity against α-amylase [52], which therefore could have provided the extract with the ability to inhibit α-amylase.

(a)

(b)

4. Conclusion

Identification of the polyphenolic compounds performed on the Pistacia lentiscus leaf extract was successfully achieved as indicated by the presence of 20 polyphenolic constituents. The total phenolic and flavonoid contents were quantified as 394.5 ± 0.08 (mg GAE/g DE) and 101.2 ± 0.095 (mg QE/g DE), respectively. The plant extract has been found to possess interesting antioxidant and antidiabetic properties. Future research should focus on elucidating the molecular mechanisms underlying the activities exhibited by the plant extracts and their active compounds. Additionally, conducting genotoxicity tests will enhance the reliability and validation of the obtained results. Finally, the molecular docking performed on the main phenolic compounds of extracts showed a marked binding affinity versus human pancreatic alpha-amylase, which allows it to explain the antidiabetic ability of the extract.

Data Availability

The data used in this study are available upon request from the corresponding author.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

The authors are sincerely thankful to MESRSFC, CNRST-Morocco, UMP, for financial support of Project PPR 15-17 and PARA1-2019 and the financial support of VPMA347/20 Project from ANPMA, CNRST-Morocco, and UMP. The authors also are thankful to Dr. Atmani Zakaria for the assistance and to Professor Talhaoui Abdelmonaem, the Head of Department of Chemistry, University of Mohammed First Oujda, for managing the analytical platform.

References

S. Zrira, “Some important aromatic and medicinal plants of Morocco,” in Medicinal and Aromatic Plants of the World, M. Neffati, H. Najjaa, and Á. Máthé, Eds., pp. 91–125, Springer Netherlands, Dordrecht, Netherlands, 2017.
View at: Publisher Site | Google Scholar
M. Bakour, H. Laaroussi, N. El Menyiy, T. Elaraj, A. El Ghouizi, and B. Lyoussi, “The beekeeping state and inventory of mellifero-medicinal plants in the north-central of Morocco,” The Scientific World Journal, vol. 2021, Article ID 9039726, 12 pages, 2021.
View at: Publisher Site | Google Scholar
M. Bammou, A. Daoudi, I. Slimani et al., “Valorisation du lentisque «Pistacia lentiscus L.»: Étude ethnobotanique, Screening phytochimique et pouvoir antibactérien,” Journal of Applied Biosciences, vol. 86, no. 1, p. 7966, 2015.
View at: Publisher Site | Google Scholar
A. Doghbage, S. Belhadj, A. Derridj et al., “Comparative eco-botanical analysis of Pistacia lentiscus L. in Algeria through morphological and ultra-structural markers related to leaves and stomata,” Revue Agrobiologia, vol. 10, pp. 1826–1836, 2020.
View at: Google Scholar
M. Beldi, H. Merzougui, and A. Lazli, “Etude ethnobotanique du Pistachier lentisque Pistacia lentiscus L. dans la wilaya d’El Tarf (Nord-est algérien)-ethnobotanical study of Pistacia lentiscus L. in El Tarf region (Northeastern Algeria),” Ethnobotany Research and Applications, vol. 21, pp. 1–18, 2021.
View at: Publisher Site | Google Scholar
A. Oulous, N. E. Daoudi, T. Harit, M. Cherfi, M. Bnouham, and F. Malek, “New pyrazole-tetrazole hybrid compounds as potent α-amylase and non-enzymatic glycation inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 69, Article ID 128785, 2022.
View at: Publisher Site | Google Scholar
A. Oulous, T. Harit, M. I. Yahyaoui, A. Asehraou, and F. Malek, “New family of tetrazole-pyrazole compounds: synthesis, characterization, antimicrobial activity and docking study,” Arabian Journal of Chemistry, vol. 16, no. 11, Article ID 105268, 2023.
View at: Publisher Site | Google Scholar
W. Elloumi, A. Mahmoudi, S. Ortiz, S. Boutefnouchet, M. Chamkha, and S. Sayadi, “Wound healing potential of quercetin-3-O-rhamnoside and myricetin-3-O-rhamnoside isolated from Pistacia lentiscus distilled leaves in rats model,” Biomedicine and Pharmacotherapy, vol. 146, Article ID 112574, 2022.
View at: Publisher Site | Google Scholar
D. Pitocco, F. Zaccardi, E. Di Stasio et al., “Oxidative stress, nitric oxide, and diabetes,” The Review of Diabetic Studies, vol. 7, no. 1, pp. 15–25, 2010.
View at: Publisher Site | Google Scholar
C. Mehenni, D. Atmani-Kilani, S. Dumarçay, D. Perrin, P. Gérardin, and D. Atmani, “Hepatoprotective and antidiabetic effects of Pistacia lentiscus leaf and fruit extracts,” Journal of Food and Drug Analysis, vol. 24, no. 3, pp. 653–669, 2016.
View at: Publisher Site | Google Scholar
H. Amhamdi, F. Aouinti, J.-P. Wathelet, and A. Elbachiri, “Chemical composition of the essential oil of Pistacia lentiscus L. from Eastern Morocco,” Records of Natural Products, vol. 3, pp. 90–95, 2009.
View at: Google Scholar
A. Romani, P. Pinelli, C. Galardi, N. Mulinacci, and M. Tattini, “Identification and quantification of galloyl derivatives, flavonoid glycosides and anthocyanins in leaves of Pistacia lentiscus L,” Phytochemical Analysis, vol. 13, no. 2, pp. 79–86, 2002.
View at: Publisher Site | Google Scholar
C. Dhieb, H. Trabelsi, S. Boukhchina, and N. Sadfi-Zouaoui, “Evaluation of antifungal and antibacterial activities of Tunisian lentisc (pistacia lentiscus L.) fruit oil,” Journal of Food and Nutrition Research, vol. 9, no. 4, pp. 177–181, 2021.
View at: Publisher Site | Google Scholar
Z. Khiya, Y. Oualcadi, H. Zerkani et al., “Chemical composition and biological activities of pistacia atlantica desf. Essential oil from Morocco,” Journal of Essential Oil Bearing Plants, vol. 24, no. 2, pp. 254–265, 2021.
View at: Publisher Site | Google Scholar
A. O. Alhadad, M. F. Elmhdwi, G. S. Salem, and S. M. Elshareef, “Evaluation the in vitro antibacterial activity of acetone leaf extracts from Pistacia lentiscus against multi-drug resistant Pseudomonas aeruginosa and Staphylococcus aureus,” Journal of Medicinal Plants, vol. 9, pp. 100–105, 2021.
View at: Google Scholar
F. Aouinti, H. Zidane, M. Tahri, J. P. Wathelet, and A. El Bachiri, “Chemical composition, mineral contents and antioxidant activity of fruits of pistacia lentiscus L. From eastern Morocco,” Journal of Materials and Environmental Science, vol. 5, pp. 199–206, 2014.
View at: Google Scholar
S. Boucheffa, W. Sobhi, A. Attoui et al., “Effect of the main constituents of Pistacia lentiscus leaves against the DPPH radical and xanthine oxidase: experimental and theoretical study,” Journal of Biomolecular Structure and Dynamics, vol. 40, no. 20, pp. 9870–9884, 2021.
View at: Publisher Site | Google Scholar
H. Mechqoq, S. Hourfane, M. El Yaagoubi et al., “Phytochemical Screening, and In Vitro Evaluation of the Antioxidant and Dermocosmetic Activities of Four Moroccan Plants: Halimium antiatlanticum, Adenocarpus artemisiifolius, Pistacia lentiscus and Leonotis nepetifolia,” Cosmetics, vol. 9, pp. 1–15, 2022.
View at: Google Scholar
S. Djebari, M. Wrona, A. Boudria et al., “Study of bioactive volatile compounds from different parts of Pistacia lentiscus L. extracts and their antioxidant and antibacterial activities for new active packaging application,” Food Control, vol. 120, Article ID 107514, 2021.
View at: Publisher Site | Google Scholar
L. Bouslama, R. Benzekri, S. Nsaibia, A. Papetti, and F. Limam, “Identification of an antiviral compound isolated from Pistacia lentiscus,” Archives of Microbiology, vol. 202, no. 9, pp. 2569–2578, 2020.
View at: Publisher Site | Google Scholar
E. Milia, S. M. Bullitta, G. Mastandrea et al., “Leaves and fruits preparations of pistacia lentiscus L.: a review on the ethnopharmacological uses and implications in inflammation and infection,” Antibiotics, vol. 10, no. 4, p. 425, 2021.
View at: Publisher Site | Google Scholar
S. Ben Khedir, M. Mzid, S. Bardaa, D. Moalla, Z. Sahnoun, and T. Rebai, “In vivo evaluation of the anti-inflammatory effect ofPistacia lentiscusfruit oil and its effects on oxidative stress,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 6108203, 12 pages, 2016.
View at: Publisher Site | Google Scholar
A. Santarsiero, A. Onzo, R. Pascale et al., “Pistacia lentiscus hydrosol: untargeted metabolomic analysis and anti-inflammatory activity mediated by NF- κ B and the citrate pathway,” Oxidative Medicine and Cellular Longevity, vol. 2020, Article ID 4264815, 14 pages, 2020.
View at: Publisher Site | Google Scholar
J. S. Bhatti, A. Sehrawat, J. Mishra et al., “Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives,” Free Radical Biology and Medicine, vol. 184, pp. 114–134, 2022.
View at: Publisher Site | Google Scholar
J. O. Unuofin and S. L. Lebelo, “Antioxidant effects and mechanisms of medicinal plants and their bioactive compounds for the prevention and treatment of type 2 diabetes: an updated review,” Oxidative Medicine and Cellular Longevity, vol. 2020, Article ID 1356893, 36 pages, 2020.
View at: Publisher Site | Google Scholar
H. Bouakline, M. Elkabous, I. Ziani, Y. Karzazi, A. Tahani, and A. El Bachiri, “Antioxidative activity of Pistacia lentiscus leaf extract main components: experimental and theoretical study,” Materials Today: Proceedings, vol. 72, pp. 3275–3279, 2023.
View at: Publisher Site | Google Scholar
T. Haloui, A. Farah, M. Balouiri et al., “Bacteriostatic and bactericidal profile of leaves and twigs essential oils of Moroccan pistacia lentiscus L,” Journal of Applied Pharmaceutical Science, vol. 5, pp. 050–053, 2015.
View at: Publisher Site | Google Scholar
S. Selim, M. S. Almuhayawi, M. T. Alharbi et al., “Insights into the antimicrobial, antioxidant, anti-SARS-CoV-2 and cytotoxic activities of pistacia lentiscus bark and phytochemical profile; in silico and in vitro study,” Antioxidants, vol. 11, no. 5, p. 930, 2022.
View at: Publisher Site | Google Scholar
M. Bozorgi, Z. Memariani, M. Mobli, M. H. Salehi Surmaghi, M. R. Shams-Ardekani, and R. Rahimi, “Five Pistacia species (P. vera, P. atlantica, P. terebinthus, P. khinjuk, and P. lentiscus): a review of their traditional uses, phytochemistry, and pharmacology,” The Scientific World Journal, vol. 2013, Article ID 219815, 33 pages, 2013.
View at: Publisher Site | Google Scholar
A. Soni and S. Sosa, “Phytochemical analysis and free radical scavenging potential of herbal and medicinal plant extracts,” Journal of Pharmacognosy and phytochemistry, vol. 2, pp. 22–29, 2013.
View at: Google Scholar
P. D. Hardt and N. Ewald, “Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes?” Experimental Diabetes Research, vol. 2011, Article ID 761950, 7 pages, 2011.
View at: Publisher Site | Google Scholar
S. Remila, D. Atmani-kilani, S. Delemasure et al., “Antioxidant, cytoprotective, anti-inflammatory and anticancer activities of Pistacia lentiscus (Anacardiaceae) leaf and fruit extracts,” European Journal of Integrative Medicine, vol. 7, no. 3, pp. 274–286, 2015.
View at: Publisher Site | Google Scholar
A. Hadini, A. Azdimousa, A. Khoulati, K. El bekkaye, and E. Saalaoui, “Valorization of Moroccan pistacia lentiscus L. Leaves: phytochemical and in vitro antioxidant activity evaluation compared to different altitudes,” The Scientific World Journal, vol. 2022, Article ID 6367663, 10 pages, 2022.
View at: Publisher Site | Google Scholar
Z. Yosr, B. H. Y. Imen, J. Rym, M. Chokri, B. Mohamed, and B. Mohamed, “Sex-related differences in essential oil composition, phenol contents and antioxidant activity of aerial parts in Pistacia lentiscus L. during seasons,” Industrial Crops and Products, vol. 121, pp. 151–159, 2018.
View at: Publisher Site | Google Scholar
A. Amrani, H. Bouakline, M. Elkabous et al., “Ceratonia siliqua L seeds extract: experimental analysis and simulation study,” Materials Today: Proceedings, vol. 72, pp. 3705–3711, 2023.
View at: Publisher Site | Google Scholar
C. Rodríguez-Pérez, R. Quirantes-Piné, N. Amessis-Ouchemoukh, K. Madani, A. Segura-Carretero, and A. Fernández-Gutierrez, “A metabolite-profiling approach allows the identification of new compounds from Pistacia lentiscus leaves,” Journal of Pharmaceutical and Biomedical Analysis, vol. 77, 2013.
View at: Publisher Site | Google Scholar
I. Ziani, H. Bouakline, M. I. Yahyaoui et al., “The effect of ethanol/water concentration on phenolic composition, antioxidant, and antimicrobial activities of Rosmarinus tournefortii de Noé hydrodistillation solid residues,” Journal of Food Measurement and Characterization, vol. 17, no. 2, pp. 1602–1615, 2022.
View at: Publisher Site | Google Scholar
O. Bekkouch, M. Harnafi, I. Touiss et al., “In VitroAntioxidant andIn VivoLipid-lowering properties ofZingiber officinalecrude aqueous extract and methanolic fraction: a follow-up study,” Evidence-based Complementary and Alternative Medicine, vol. 2019, Article ID 9734390, 13 pages, 2019.
View at: Publisher Site | Google Scholar
S. Bouknana, N. E. Daoudi, M. Bouhrim et al., “Ammodaucus leucotrichus Coss. and Durieu: antihyperglycemic activity via the inhibition of α-amylase, α-glucosidase, and intestinal glucose absorption activities and its chemical composition,” Journal of Pharmacy and Pharmacognosy Research, vol. 10, no. 1, pp. 94–103, 2022.
View at: Publisher Site | Google Scholar
S. Chigurupati, F. S. Alharbi, S. Almahmoud et al., “Molecular docking of phenolic compounds and screening of antioxidant and antidiabetic potential of Olea europaea L. Ethanolic leaves extract,” Arabian Journal of Chemistry, vol. 14, no. 11, Article ID 103422, 2021.
View at: Publisher Site | Google Scholar
K. Qabaha, S. A. Ras, J. Abbadi, and F. Al-Rimawi, “Anti-inflammatory activity of Eucalyptus spp. and Pistascia lentiscus leaf extracts,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 13, no. 5, pp. 1–6, 2016.
View at: Publisher Site | Google Scholar
S. Ouahabi, E. H. Loukili, A. Elbouzidi et al., “Pharmacological properties of chemically characterized extracts from mastic tree: in vitro and in silico assays,” Life, vol. 13, no. 6, p. 1393, 2023.
View at: Publisher Site | Google Scholar
A. Bampouli, K. Kyriakopoulou, G. Papaefstathiou et al., “Evaluation of total antioxidant potential of Pistacia lentiscus var. chia leaves extracts using UHPLC-HRMS,” Journal of Food Engineering, vol. 167, pp. 25–31, 2015.
View at: Publisher Site | Google Scholar
M. Barbouchi, K. Elamrani, M. El Idrissi, and M. Choukrad, “A comparative study on phytochemical screening, quantification of phenolic contents and antioxidant properties of different solvent extracts from various parts of Pistacia lentiscus L,” Journal of King Saud University Science, vol. 32, no. 1, pp. 302–306, 2020.
View at: Publisher Site | Google Scholar
Z. Amel, B. Nabila, G. Nacéra, and T. Fethi, “Assessment of phytochemical composition and antioxidant properties of extracts from the leaf, stem, fruit and root of pistacia lentiscus L,” International Journal of Pharmacognosy and Phytochemical Research, vol. 8, pp. 627–633, 2016.
View at: Google Scholar
N. Amessis-ouchemoukh, K. Madani, P. L. Falé, M. L. Serralheiro, M. E. M. Araújo, and M. Araújo, “Antioxidant capacity and phenolic contents of some Mediterranean medicinal plants and their potential role in the inhibition of cyclooxygenase-1 and acetylcholinesterase activities,” Industrial Crops and Products, vol. 53, pp. 6–15, 2014.
View at: Publisher Site | Google Scholar
C. Proença, M. Freitas, D. Ribeiro et al., “Evaluation of a flavonoids library for inhibition of pancreatic α-amylase towards a structure–activity relationship,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 34, no. 1, pp. 577–588, 2019.
View at: Publisher Site | Google Scholar
C. He, X. Liu, Z. Jiang, S. Geng, H. Ma, and B. Liu, “Interaction mechanism of flavonoids and α-glucosidase: experimental and molecular modelling studies,” Foods, vol. 8, no. 9, p. 355, 2019.
View at: Publisher Site | Google Scholar
J.-S. Kim, C.-S. Kwon, and K. H. Son, “Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid,” Bioscience, Biotechnology, and Biochemistry, vol. 64, no. 11, pp. 2458–2461, 2000.
View at: Publisher Site | Google Scholar
H. Ali, P. J. Houghton, and A. Soumyanath, “α-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus,” Journal of Ethnopharmacology, vol. 107, no. 3, pp. 449–455, 2006.
View at: Publisher Site | Google Scholar
M. Foddai, V. Kasabri, F. U. Afifi, E. Azara, G. L. Petretto, and G. Pintore, “In vitro inhibitory effects of Sardinian Pistacia lentiscus L. and Pistacia terebinthus L. on metabolic enzymes: pancreatic lipase, α-amylase, and α-glucosidase,” Starch-Stärke, vol. 67, no. 1-2, pp. 204–212, 2015.
View at: Publisher Site | Google Scholar
M. Rahman, J. J. Browne, J. Van Crugten, M. F. Hasan, L. Liu, and B. J. Barkla, “In silico, molecular docking and in vitro antimicrobial activity of the major rapeseed seed storage proteins,” Frontiers in Pharmacology, vol. 11, p. 1340, 2020.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2024 Hamza Bouakline et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

238

Downloads

214

Citations